Search publications
45 results found
-
Dutch health insurers may distribute the additional costs of effects of the coronavirus crisis among each other
This year, Dutch health insurers may distribute the additional costs of the effects of the coronavirus (COVID-19) crisis among themselves. The Netherlands Authority for Consumers and Markets has come to this conclusion following questions posed by health … -
ACM closes investigation into drug manufacturer AbbVie, competitors get more room now
Drug manufacturer AbbVie has stated that it will not force hospitals to purchase exclusively or to a large extent from AbbVie through discount schemes (or rebate programs). AbbVie has made these assurances following an investigation conducted by the … -
ACM studies: the insured’s diversity of wishes affects the negotiation balance between health insurers and hospitals
Approximately one in three insured believe that health insurers should negotiate fiercely in order to keep premiums low. Almost the same percentage of insured believe that health insurers should predominantly offer unlimited choice in health care options. … -
ACM: room for collaboration involving the distribution of essential drugs for COVID-19 patients
Hospitals, hospital pharmacies, and pharmaceutical wholesalers are allowed to collaborate closely with each other during the current coronavirus (COVID-19) outbreak in order to prevent or reduce any shortages of essential drugs. To that end, the National … -
Room for collaborations as part of ‘the Right Care in the Right Place’
Health care providers and health insurers have to collaborate, as part of the initiative called ‘the Right Care in the Right Place’ (in Dutch: De Juiste Zorg op de Juiste Plek). Many forms of collaborations are allowed. However, collaborations can also go … -
ACM Policy Rule on arrangements as part of the movement called ‘The right care in the right place’ (JZOJP)
Health care providers and health insurers have to collaborate, as part of the initiative called ‘the Right Care in the Right Place’ (in Dutch: De Juiste Zorg op de Juiste Plek). Many forms of collaborations are allowed. However, collaborations can also go … -
Health insurers and hospitals leave full potential of collective procurement of prescription drugs untapped
Hospitals and health insurers are not yet taking full advantage of the potential benefits that their collaborations in drug procurement are able to offer, in particular with regard to the strengthening of their bargaining positions. To this end, they can … -
ACM: a broad-based effort is needed for long-term competition in anti-rheumatic prescription drugs
The expiration of patents and the market entry of competing drugs have led to drops in the net purchasing prices of three important anti-rheumatic prescription drugs, the so-called TNF-alpha inhibitors. As a result, hospitals have been able to save … -
Sector inquiry into TNF alpha inhibitors
The Netherlands Authority for Consumers and Markets (ACM) has conducted a sector inquiry into TNF alpha inhibitors. TNF-alpha inhibitors are biological drugs that are mostly used by patients with rheumatic disorders. Hospitals buy these drugs for their … -
When merging, health care providers must identify health care more accurately
Hospitals and independent treatment centers that wish to merge have to provide the Netherlands Authority for Consumers and Markets (ACM) more detailed information for the analysis of product markets. This is one of the changes in the revised notification …